Virtual rehabilitation: A therapy for parkinsonism?
Objective: To determine the effectiveness of vestibular rehabilitation exercises that use virtual reality technology through pre and post application of the Berg Balance Scale (BBS),…Predicting therapeutic effects of atomoxetine and citalopram on response inhibition in Parkinson’s disease
Objective: (1) To reassess the behavioral impact of novel noradrenergic (atomoxetine) and serotonergic (citalopram) therapies for impulsivity and (2) to develop predictive models to identify…Factors associated with falling in early, treated Parkinson’s disease: The NET-PD LS1 cohort
Objective: To examine baseline characteristics associated with falling in PD using the NET-PD LS-1 dataset. Background: Recognizing the factors associated with falling in Parkinson's disease…Efficacy and feasibility study of the Medido eletronic medication dispenser in Parkinson’s disease: A multicentre randomized controlled trial
Objective: The aim of this randomized controlled study was to assess the effect of the electronic medication dispenser, Medido, on physical limitations in PD. Background:…Safety and clinical effects of NTCELL® [immunoprotected (alginate-encapsulated) porcine choroid plexus cells for xenotransplantation] in patients with Parkinson’s disease (PD): 81 to 130 weeks follow-up
Objective: To follow the clinical status of 4 PD patients transplanted with NTCELL out to 81-130 weeks. Background: NTCELL comprises neonatal porcine choroid plexus cells…Hospitalisation following different initial therapies in early Parkinson’s disease: Analysis of hospital episodes statistics from the PD MED EARLY trial
Objective: To compare hospitalisation rates of Parkinson's disease (PD) patients randomised between three different classes of oral medications used for early PD treatment. Background: PD…Subthalamic deep brain stimulation vs. intraduodenal levodopa infusion: A long-term retrospective comparative study
Objective: To analyze the long-term retrospective data of patients treated with Levodopa/carbidopa intestinal gel infusion (LCIG) and subthalamic nucleus deep brain stimulation (STN-DBS) in two…Improving provision of Parkinson’s disease exercise classes
Objective: (1) To identify common barriers and limitations related to the delivery of Parkinson's disease (PD) exercise classes; (2) To recommend interventions with widespread applicability…Auditory cues during obstacle crossing increase gait asymmetry in neurologically health individuals but not in people with Parkinson’s disease
Objective: To investigate the influence of auditory cue on gait asymmetry in an environment unobstructed and with obstacle in people with Parkinson's disease (PD) and…Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
Objective: To evaluate baseline predictors and longitudinal impact of amantadine use in Parkinson's disease (PD). Background: There is preclinical data that amantadine has neuroprotective properties,…
- « Previous Page
- 1
- …
- 101
- 102
- 103
- 104
- 105
- …
- 207
- Next Page »